GeneDx Holdings (WGS) Profit After Tax (2020 - 2026)
GeneDx Holdings' (WGS) quarterly Profit After Tax came in at -$18.1 million in Q2 2026, down 267.28% year-over-year from $10.8 million in Q2 2025, and up 71.56% quarter-over-quarter from -$63.6 million in Q1 2026.
Analysis
GeneDx Holdings (WGS) Profit After Tax (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has reported Profit After Tax for 7 consecutive years, with -$18.1 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Profit After Tax fell 267.28% year-over-year to -$18.1 million in Q2 2026; TTM through Jun 2026 was -$107.0 million, a 7706.76% decrease from a year earlier, with the FY2025 full-year figure at -$21.0 million, up 59.8% from the prior year.
- Profit After Tax was -$18.1 million for Q2 2026 at GeneDx Holdings, up from -$63.6 million in the prior quarter.
- Over five years, Profit After Tax peaked at $10.8 million in Q2 2025 and troughed at -$308.8 million in Q4 2022.
- A 5-year average of -$48.9 million and a median of -$27.5 million in 2023 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax soared 137.05% in 2025 and plunged 873.64% in 2026, its largest moves.
- Over 5 years, Profit After Tax stood at -$308.8 million in 2022, then soared by 91.65% to -$25.8 million in 2023, then jumped by 121.1% to $5.4 million in 2024, then slumped by 424.86% to -$17.7 million in 2025, then dropped by 2.35% to -$18.1 million in 2026.
- The last three Profit After Tax figures came in at -$18.1 million (Q2 2026), -$63.6 million (Q1 2026), and -$17.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | -66.97 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 334.00 Mn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 299.10 Mn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | -120.14 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 5.64 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | -1.00 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 53.64 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 8.05 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | -39.94 Mn |
| 10 | GeneDx Holdings | 3.01 Bn | 2.88 Bn | 78.24 Mn | -18.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -18.08 Mn |
| Mar 31, 2026 | -63.57 Mn |
| Dec 31, 2025 | -17.67 Mn |
| Sep 30, 2025 | -7.64 Mn |
| Jun 30, 2025 | 10.81 Mn |
| Mar 31, 2025 | -6.53 Mn |
| Dec 31, 2024 | 5.44 Mn |
| Sep 30, 2024 | -8.31 Mn |
| Jun 30, 2024 | -29.17 Mn |
| Mar 31, 2024 | -20.37 Mn |
| Dec 31, 2023 | -25.77 Mn |
| Sep 30, 2023 | -42.29 Mn |
| Jun 30, 2023 | -46.72 Mn |
| Mar 31, 2023 | -60.99 Mn |
| Dec 31, 2022 | -308.76 Mn |
| Sep 30, 2022 | -77.58 Mn |
| Jun 30, 2022 | -85.74 Mn |
| Mar 31, 2022 | -76.90 Mn |
| Dec 31, 2021 | -40.19 Mn |
| Sep 30, 2021 | 32.73 Mn |